Deterioration of COVID-19 vaccine efficacy by antipsychotic medications in schizophrenia patients
ABSTRACT It has been previously documented that some antipsychotic medications could deteriorate the protective efficacy of vaccines. Likewise, we have initially observed that a significantly increased number of schizophrenic inpatients became ill irrespective of COVID-19 vaccination compared to hea...
Saved in:
| Main Authors: | Takashi Kusunoki, Naomi Tsubata, Nariaki Iijima, Shiho Mitsugi, Toru Nagasaka, Takeshi Senga, Ryoichi Ichie, Takashi Okamoto |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2025-05-01
|
| Series: | Microbiology Spectrum |
| Subjects: | |
| Online Access: | https://journals.asm.org/doi/10.1128/spectrum.00021-25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antipsychotic medication for behaviors that challenge in individuals with intellectual disabilities: a clinically informed review
by: Alessandro Pascucci, et al.
Published: (2025-07-01) -
The impact of aripiprazole on neurocognitive function in individuals at clinical high risk for psychosis: A comparison with olanzapine and non-antipsychotic treatment
by: JiaHui Zeng, et al.
Published: (2025-01-01) -
METHODS ELABORATION ON DETECTION OF SOME ATYPICAL NEUROLYTIC AGENTS FOR CHEMICAL AND TOXICOLOGICAL ANALYSIS
by: I. P. Remezova, et al.
Published: (2015-09-01) -
Comparative effectiveness of aripiprazole and olanzapine on neurocognitive profile of patients with schizophrenia
by: Sanya Sharma, et al.
Published: (2023-10-01) -
Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: a retrospective cohort study
by: Yi-Ting Yeh, et al.
Published: (2025-07-01)